AHA Coding Clinic® for HCPCS - 2017 Issue 1; Ask the Editor
Xen glaucoma treatment
The Food and Drug Administration (FDA) approved the Xen Glaucoma Treatment System in November 2016. The system is used to treat intraocular pressure (IOP) in patients with refractory glaucoma or in patients with primary open angle glaucoma and pseudoexfoliative or pigmentary glaucoma with open angles that are unresponsive to maximum tolerated medical therapy. The system consists of an implantable gel stent and an injector. Is there a Level II HCPCS codes that describes the Xen Glaucoma Treatment System? ...
To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.
Thank you for choosing Find-A-Code, please Sign In to remove ads.